Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Carter

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
AIDS and Behavior|May 18, 2021
Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural StatesGregory Carter, Beth Meyerson, Patrick Rivers, et al.
General Hospital Psychiatry|March 18, 2022
A pilot study of a text message and online brief contact intervention following self-harm or a suicide attempt: A mixed methods evaluationNatasha Josifovski, Fiona Shand, Kirsten Morley, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|May 9, 2026
Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)Gregory Carter, Maree Hackett, Stevan Nikolin, et al.
Science (New York, N.Y.)|May 23, 2015
RNA structure. Structure of the HIV-1 RNA packaging signalSarah C Keane, Xiao Heng, Kun Lu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 28, 2022
ALSUntangled #64: butyratesYuyao Sun, Richard Bedlack, Carmel Armon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 23, 2022
ALSUntangled #65: glucocorticoid corticosteroidsJill Ann Goslinga, Mark Terrelonge, Richard Bedlack, et al.
Orphanet Journal of Rare Diseases|October 17, 2021
A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1AShahram Attarian, Peter Young, Thomas H Brannagan, et al.
Orphanet Journal of Rare Diseases|April 2, 2024
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1AShahram Attarian, Peter Young, Thomas H Brannagan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2025
ALSUntangled #79: alpha-lipoic acidAlaina Giacobbe, James Hiana, Olivia Wang, et al.
Trials|June 6, 2019
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependenceRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
AIDS and Behavior|May 18, 2021
Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural StatesGregory Carter, Beth Meyerson, Patrick Rivers, et al.
General Hospital Psychiatry|March 18, 2022
A pilot study of a text message and online brief contact intervention following self-harm or a suicide attempt: A mixed methods evaluationNatasha Josifovski, Fiona Shand, Kirsten Morley, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|May 9, 2026
Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)Gregory Carter, Maree Hackett, Stevan Nikolin, et al.
Science (New York, N.Y.)|May 23, 2015
RNA structure. Structure of the HIV-1 RNA packaging signalSarah C Keane, Xiao Heng, Kun Lu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 28, 2022
ALSUntangled #64: butyratesYuyao Sun, Richard Bedlack, Carmel Armon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 23, 2022
ALSUntangled #65: glucocorticoid corticosteroidsJill Ann Goslinga, Mark Terrelonge, Richard Bedlack, et al.
Orphanet Journal of Rare Diseases|October 17, 2021
A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1AShahram Attarian, Peter Young, Thomas H Brannagan, et al.
Orphanet Journal of Rare Diseases|April 2, 2024
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1AShahram Attarian, Peter Young, Thomas H Brannagan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2025
ALSUntangled #79: alpha-lipoic acidAlaina Giacobbe, James Hiana, Olivia Wang, et al.
Trials|June 6, 2019
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependenceRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Pageof 14